In a National Bureau of Economic Research Working Paper, Amanda Starc and Keith Marzilli Ericson (Boston University) examine how much consumers value network breadth by measuring and comparing insurance plans, and plan choice, on the Massachusetts health insurance exchange. ‘Limited’ or ‘narrow’ network plans are growing in popularity yet there is currently little evidence on consumer valuation of breadth as a plan attribute. Using data from the Massachusetts exchange and the Massachusetts All-Payer Claims Database, Starc and Marzilli quantify the breadth of insurer-hospital...
(An edited version of this post appeared in Philly.com)
US health care spending has never grown as slowly as it did last year.
Dwight D. Eisenhower was in the Oval Office when the US government began recording health care spending in 1960. Since that time, growth in health care spending has never been lower than the 3.6% annual rate reported by researchers from the Centers for Medicare and Medicaid Services a few weeks ago in the journal Health Affairs.
In a Perspective in today’s New England Journal of Medicine, David Grande, LDI's Co-Director of Health Policy, and colleagues write about new digital forms of pharmaceutical and medical device marketing to physicians. The same technologies that can be used to support clinical practice—such as electronic health records, social media, and mobile applications—can also be used to conduct market research and to market directly to physicians. Grande and colleagues write:
LDI Senior Fellow Mark Pauly wants to have a conversation about the ACA’s mandatory coverage of preventive care.
Sovaldi, the $84,000 Hepatitis C drug developed by Gilead Sciences, has sparked controversy while marching toward worldwide sales set to exceed $11 billion in 2014. The blockbuster drug’s price is the main sticking point in the debate: critics argue that the cost is unsustainable and will cause payers to restrict treatment for the estimated 3.2 million patients in the United States who live with Hepatitis C, some of whom will develop liver complications.
Newly-published studies by Senior Fellows Mark Neuman, Jeffrey Silber, Rachel Werner, and colleagues have direct implications for the management of hip fractures, which afflict more than 300,000 older adults each year.
Cross-posted with The Field Clinic Blog
Lest we forget that guidelines are (and should be) living, breathing documents, LDI Senior Fellows Mark Neuman and Sandy Schwartz provide an excellent reminder in a new study in JAMA that reviews the “durability” of recommendations across serial versions of the same cardiology guidelines.
In Health Care Management Science, Dylan Small, Scott Lorch and colleagues discuss different mechanisms of risk adjustment used in hospital performance evaluations. Accurate risk adjustment is critical to the reliable assessment and comparison of hospitals. Hospitals are commonly assessed using evaluations that measure their actual outcomes as compared to their risk-adjusted expected outcomes, which take into account factors like patient mix in order to compare hospitals on a level playing field. The authors propose ensemble of trees approaches as superior alternatives to the logistic...